PreveCeutical Medical Inc.
PRVCF
$0.02
$0.000.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.41M | 1.96M | 2.15M | 1.80M | 1.49M |
| Depreciation & Amortization | 11.10K | 11.10K | 10.30K | 9.50K | 8.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.56M | 2.14M | 2.32M | 1.93M | 1.58M |
| Operating Income | -1.56M | -2.14M | -2.32M | -1.93M | -1.58M |
| Income Before Tax | -542.90K | -1.07M | -1.21M | -2.23M | -1.86M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.54 | -1.07 | -1.21 | -2.23 | -1.86 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 76.40K | 105.80K | 105.80K | 29.40K | 29.40K |
| Net Income | -466.60K | -962.90K | -1.11M | -2.21M | -1.83M |
| EBIT | -1.56M | -2.14M | -2.32M | -1.93M | -1.58M |
| EBITDA | -1.55M | -2.13M | -2.31M | -1.92M | -1.57M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 2.37B | 2.34B | 2.27B | 2.21B | 2.18B |
| Average Diluted Shares Outstanding | 2.37B | 2.34B | 2.27B | 2.21B | 2.18B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |